Authors: Claire Campbell, PhD ⊕, Truveta, Inc, Bellevue, WA, USA Sarah Eng, MPH ⊕, Truveta, Inc, Bellevue, WA, USA Jeffrey Ratto, PhD ⊕, Truveta, Inc, Bellevue, WA, USA Katie Gilbert, MPH ⊕, Truveta, Inc, Bellevue, WA, USA Amy Austin, MHI ⊕, Truveta, Inc, Bellevue, WA, USA Ekaterina Khlystova, PhD ⊕, Truveta, Inc, Bellevue, WA, USA Sunny Guin, PhD ⊕, Truveta, Inc, Bellevue, WA, USA Vidya Venkataraman, MPH, PhD ⊕ Truveta, Inc, Bellevue, WA, USA Compared with adults who started a non-GLP-1 anti-obesity medication, GLP-1 initiators were older, less likely to be female, and had more cardiometaboli